These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

313 related items for PubMed ID: 9794476

  • 1. LY353381 x HCl: an improved benzothiophene analog with bone efficacy complementary to parathyroid hormone-(1-34).
    Sato M, Zeng GQ, Rowley E, Turner CH.
    Endocrinology; 1998 Nov; 139(11):4642-51. PubMed ID: 9794476
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Biosynthetic human parathyroid hormone (1-34) effects on bone quality in aged ovariectomized rats.
    Sato M, Zeng GQ, Turner CH.
    Endocrinology; 1997 Oct; 138(10):4330-7. PubMed ID: 9322947
    [Abstract] [Full Text] [Related]

  • 7. Sequential treatment with basic fibroblast growth factor and PTH is more efficacious than treatment with PTH alone for increasing vertebral bone mass and strength in osteopenic ovariectomized rats.
    Iwaniec UT, Mosekilde L, Mitova-Caneva NG, Thomsen JS, Wronski TJ.
    Endocrinology; 2002 Jul; 143(7):2515-26. PubMed ID: 12072383
    [Abstract] [Full Text] [Related]

  • 8. Daily treatment of aged ovariectomized rats with human parathyroid hormone (1-84) for 12 months reverses bone loss and enhances trabecular and cortical bone strength.
    Fox J, Miller MA, Newman MK, Metcalfe AF, Turner CH, Recker RR, Smith SY.
    Calcif Tissue Int; 2006 Oct; 79(4):262-72. PubMed ID: 16969596
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Prolonged treatments with antiresorptive agents and PTH have different effects on bone strength and the degree of mineralization in old estrogen-deficient osteoporotic rats.
    Cheng Z, Yao W, Zimmermann EA, Busse C, Ritchie RO, Lane NE.
    J Bone Miner Res; 2009 Feb; 24(2):209-20. PubMed ID: 18847326
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Droloxifene, a new estrogen antagonist/agonist, prevents bone loss in ovariectomized rats.
    Ke HZ, Simmons HA, Pirie CM, Crawford DT, Thompson DD.
    Endocrinology; 1995 Jun; 136(6):2435-41. PubMed ID: 7750465
    [Abstract] [Full Text] [Related]

  • 14. New bone formation with teriparatide [human parathyroid hormone-(1-34)] is not retarded by long-term pretreatment with alendronate, estrogen, or raloxifene in ovariectomized rats.
    Ma YL, Bryant HU, Zeng Q, Schmidt A, Hoover J, Cole HW, Yao W, Jee WS, Sato M.
    Endocrinology; 2003 May; 144(5):2008-15. PubMed ID: 12697709
    [Abstract] [Full Text] [Related]

  • 15. Raloxifene and teriparatide (hPTH 1-34) have complementary effects on the osteopenic skeleton of ovariectomized rats.
    Ma YL, Bryant HU, Zeng Q, Schmidt A, Jee WS, Sato M.
    J Bone Miner Metab; 2005 May; 23 Suppl():62-8. PubMed ID: 15984416
    [Abstract] [Full Text] [Related]

  • 16. Parathyroid hormone monotherapy and cotherapy with antiresorptive agents restore vertebral bone mass and strength in aged ovariectomized rats.
    Li M, Mosekilde L, Søgaard CH, Thomsen JS, Wronski TJ.
    Bone; 1995 Jun; 16(6):629-35. PubMed ID: 7669439
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Advantages of raloxifene over alendronate or estrogen on nonreproductive and reproductive tissues in the long-term dosing of ovariectomized rats.
    Sato M, Bryant HU, Iversen P, Helterbrand J, Smietana F, Bemis K, Higgs R, Turner CH, Owan I, Takano Y, Burr DB.
    J Pharmacol Exp Ther; 1996 Oct; 279(1):298-305. PubMed ID: 8859007
    [Abstract] [Full Text] [Related]

  • 19. Effects of reciprocal treatment with estrogen and estrogen plus parathyroid hormone on bone structure and strength in ovariectomized rats.
    Shen V, Birchman R, Xu R, Otter M, Wu D, Lindsay R, Dempster DW.
    J Clin Invest; 1995 Nov; 96(5):2331-8. PubMed ID: 7593620
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.